Work

Sustained Clinical Response to Olaparib in a Patient with Metastatic Pancreatic Cancer and Somatic ATM Mutation R2034Ter: A Case Report

Year: 2025

Type: article

Study design: Case Report

Source: Oncology Research and Treatment

DOI: 10.1159/000545975

Authors: Marlies Vornhülz, Marianne Angelberger, Simon Sirtl, Alexander B. Philipp, Daniel Rössler, Katarina Ondrejkova, Daniel Markwardt, Kathrin Heinrich, Christoph Benedikt Westphalen, Volker Heinemann, Andreas Jung, Paul Rogowski, Maximilian Niyazi, Alexander Kleger, Julia Mayerle, Georg Beyer

Institutions: LMU Klinikum, Ludwig-Maximilians-Universität München, Pathologisches Institut, University of Tübingen, University Hospital Ulm

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409763897

FWCI: 0.723

Cites: 29

Cited by: 2

Related to: 10